Modern device technologies.

Implantable cardiac devices for arrhythmias and related conditions are a rapidly evolving field, with a constant stream of technologies being developed. There are a number of novel devices, other than conventional pacemakers and implantable defibrillators, currently being developed that have the potential to greatly improve patient outcomes. This paper reviews the important recent technologies, the subcutaneous defibrillator, cardiac contraction modulation, the HeartPOD and CardioMEMS heart failure monitors, left atrial appendage closure devices and leadless cardiac pacing. The features of these devices, the results to date, and their possible clinical utility are discussed.

[1]  Bernhard Meier,et al.  Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. , 2005, Journal of the American College of Cardiology.

[2]  E. Wood,et al.  Positive and negative inotropic effects by constant electric currents or current pulses applied during the cardiac action potential. , 1966, Helvetica physiologica et pharmacologica acta.

[3]  C. Lau,et al.  Temporary leadless pacing in heart failure patients with ultrasound-mediated stimulation energy and effects on the acoustic window. , 2009, Heart rhythm.

[4]  Andrea Natale,et al.  Percutaneous Closure of the Left Atrial Appendage. , 2012, Cardiac electrophysiology clinics.

[5]  Alexander H Maass,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, The New England journal of medicine.

[6]  Bernhard Meier,et al.  Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  M. Wolzt,et al.  First Human Chronic Experience with Cardiac Contractility Modulation by Nonexcitatory Electrical Currents for Treating Systolic Heart Failure: , 2004, Journal of cardiovascular electrophysiology.

[8]  R. Elmqvist.  Review of Early Pacemaker Development , 1978, Pacing and clinical electrophysiology : PACE.

[9]  W. Grimm,et al.  Complications of Implantable Cardioverter Defibrillator Therapy in 440 Consecutive Patients , 2005, Pacing and clinical electrophysiology : PACE.

[10]  W. Maisel,et al.  Implantable cardioverter-defibrillator lead performance. , 2008, Circulation.

[11]  R. Erbel,et al.  Leadless Pacing of the Heart Using Induction Technology: A Feasibility Study , 2009, Pacing and clinical electrophysiology : PACE.

[12]  P. Neužil,et al.  PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[14]  L. Stevenson,et al.  The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. , 1989, JAMA.

[15]  Bruce D. Johnson,et al.  Repeat Length Polymorphism of the Serotonin Transporter Gene Influences Pulmonary Artery Pressure in Heart Failure , 2006, American heart journal.

[16]  森田 英晃.  Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure , 2003 .

[17]  A. Lazarus,et al.  Multisite Pacing for End‐Stage Heart Failure: Early Experience , 1996, Pacing and clinical electrophysiology : PACE.

[18]  B. Kaye,et al.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings , 1981 .

[19]  R. Bourge,et al.  Comparison of a radiofrequency-based wireless pressure sensor to swan-ganz catheter and echocardiography for ambulatory assessment of pulmonary artery pressure in heart failure. , 2007, Journal of the American College of Cardiology.

[20]  A. Gage,et al.  A transistorized, self-contained, implantable pacemaker for the long-term correction of complete heart block. , 1960, Surgery.

[21]  H. Gavras.  Oral milrinone in severe chronic heart failure. , 1992, The New England journal of medicine.

[22]  W. Lederer,et al.  Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. , 1997, Science.

[23]  Nora Toma,et al.  An entirely subcutaneous implantable cardioverter-defibrillator. , 2010, Maedica.

[24]  S. Gallagher,et al.  Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance , 2011, Heart.

[25]  D. Burkhoff,et al.  A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. , 2011, American heart journal.

[26]  William T. Abraham,et al.  Superior Performance of Intrathoracic Impedance-Derived fluid Index versus Daily Weight monitoring in Heart Failure Patients: Results of the Fluid Accumulation Status Trial (FAST) , 2009 .

[27]  E H Wood,et al.  Inotropic Effects of Electric Currents , 1969, Circulation research.

[28]  P. Neužil,et al.  PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. , 2010 .

[29]  J. W. Spickler,et al.  Totally self-contained intracardiac pacemaker. , 1970, Journal of electrocardiology.

[30]  William T. Abraham,et al.  Physician-Directed Patient Self-Management of Left Atrial Pressure in Advanced Chronic Heart Failure , 2010, Circulation.

[31]  M. Zile,et al.  Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. , 2008, Journal of the American College of Cardiology.

[32]  G. Schuler,et al.  Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[33]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[34]  D. Burkhoff,et al.  A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics. , 2008, American heart journal.